Knight Therapeutics Inc T.GUD

Alternate Symbol(s): KHTRF

Healthcare Biotechnology

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.

TSX:GUD - Post by User

Knight Therapeutics Inc

Bullboard Posts

Comment by Stylesson Apr 21, 2014 1:08pm

484 Views

Post# 22472937

RE:RE:RE:RE TSX Listing

i don't average 50-60% returns on the stocks i buy without knowing a few things.

With GUD, i knew discipline was key. Guys who bought at +7 bucks will get slaughtered in the short term. Key is to be patient and wait for an opportunity. the free trade fall was predicatable.

Sub 6 is a great price to start nibbling.

Bullboard Posts

Quantum eMotion claps back at partner's criticism